Education
About Us
Working with TipRanks
Follow Us
Christopher Maxwell Fullerton Insider Profile
4 Followers
Christopher Maxwell Fullerton, Director at Paradigm Biopharmaceuticals, holds 1.07M shares in Paradigm Biopharmaceuticals (Ticker: PBIGF), holds 254.06K shares in XTEK Limited (Ticker: AU:HCL), holds 0.00 shares in Life (Ticker: CORFF). Most recently, Christopher Maxwell Fullerton Bought ― shares of Paradigm Biopharmaceuticals on Nov 19, 2019 for an estimated value of $301.05K.
Christopher Maxwell Fullerton Paradigm Biopharmaceuticals (PBIGF)Director
Paradigm Biopharmaceuticals (PBIGF)
Director
Ranked #8,116 out of 106,131 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+128.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christopher Maxwell Fullerton holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 03, 2019 - Jul 03, 2020
Return:+136.60%
The most profitable trade made by Christopher Maxwell Fullerton
Christopher Maxwell Fullerton's Trading History
Paradigm Biopharmaceuticals
Nov 19, 2019
Director
Informative Buy
301.05K
$234.33K
XTEK Limited
―
Director
―
AU$50.81K
Life
―
―
―
$0.00
Environmental Group Limited
―
Director
―
AU$2.44M
Neuphoria Therapeutics
―
Director
―
$16.57M
List of latest transactions for each holding click on a transaction to see Christopher Maxwell Fullerton's performance on stock
You May Also Like
Christopher Maxwell Fullerton insider profile FAQ
What is the percentage of profitable transactions made by Christopher Maxwell Fullerton?
The percentage of profitable transactions made by Christopher Maxwell Fullerton is 100%.
What is the average return per transaction made by Christopher Maxwell Fullerton?
The average return per transaction made by Christopher Maxwell Fullerton is 128.40%.
What stocks does Christopher Maxwell Fullerton hold?
Christopher Maxwell Fullerton holds: PBIGF, AU:HCL, CORFF, AU:EGL, NEUP stocks.
What was Christopher Maxwell Fullerton’s latest transaction?
Christopher Maxwell Fullerton latest transaction was an Informative Buy of $301.05K.
What was Christopher Maxwell Fullerton's most profitable transaction?
Christopher Maxwell Fullerton’s most profitable transaction was an Informative Buy of PBIGF stock on July 3, 2019. The return on the trade was 136.60%.
What is Christopher Maxwell Fullerton's role in Paradigm Biopharmaceuticals?
Christopher Maxwell Fullerton's role in Paradigm Biopharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.